US Stock MarketDetailed Quotes

VANIW VIVANI MEDICAL INC C/WTS 14/03/2024 (TO PUR COM)

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Nov 29 09:30 ET
0Market Cap0.00P/E (TTM)

VIVANI MEDICAL INC C/WTS 14/03/2024 (TO PUR COM) Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-3.41M
-38.57%-3.18M
-43.72%-10.95M
-2.29M
-7.62M
Net income from continuing operations
---4.1M
-31.37%-3.92M
-37.65%-12.77M
---2.99M
---9.28M
Operating gains losses
----
----
---641K
----
----
Depreciation and amortization
--87K
-5.68%83K
-2.54%345K
--88K
--354K
Other non cash items
---17K
258.82%27K
----
---17K
--123K
Change In working capital
--191K
71.26%298K
208.90%451K
--174K
--146K
-Change in prepaid assets
---120K
-208.93%-61K
163.35%102K
--56K
---161K
-Change in payables and accrued expense
--311K
209.48%359K
44.40%335K
--116K
--232K
-Change in other current liabilities
--0
--0
-81.33%14K
--2K
--75K
Cash from discontinued investing activities
Operating cash flow
---3.45M
-38.57%-3.18M
-43.72%-10.95M
---2.29M
---7.62M
Investing cash flow
Cash flow from continuing investing activities
-86K
76.92%-30K
-281.33%-572K
-130K
-150K
Net PPE purchase and sale
---86K
76.92%-30K
-281.33%-572K
---130K
---150K
Cash from discontinued investing activities
Investing cash flow
---86K
76.92%-30K
-281.33%-572K
---130K
---150K
Financing cash flow
Cash flow from continuing financing activities
12K
265.34%8M
26.48%11.62M
2.19M
9.19M
Net issuance payments of debt
----
----
--0
----
--637K
Net common stock issuance
--12K
-99.95%1K
35.91%11.62M
--2.19M
--8.55M
Net other financing activities
--0
--8M
----
----
----
Cash from discontinued financing activities
Financing cash flow
--12K
265.34%8M
26.48%11.62M
--2.19M
--9.19M
Net cash flow
Beginning cash position
--6.97M
4.66%2.18M
213.88%2.08M
--2.08M
--663K
Current changes in cash
---3.52M
2,166.81%4.8M
-93.09%98K
---232K
--1.42M
End cash Position
--3.45M
277.12%6.97M
4.71%2.18M
--1.85M
--2.08M
Free cash flow
---3.54M
-32.37%-3.21M
-48.31%-11.52M
---2.42M
---7.77M
Currency Unit
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -3.41M-38.57%-3.18M-43.72%-10.95M-2.29M-7.62M
Net income from continuing operations ---4.1M-31.37%-3.92M-37.65%-12.77M---2.99M---9.28M
Operating gains losses -----------641K--------
Depreciation and amortization --87K-5.68%83K-2.54%345K--88K--354K
Other non cash items ---17K258.82%27K-------17K--123K
Change In working capital --191K71.26%298K208.90%451K--174K--146K
-Change in prepaid assets ---120K-208.93%-61K163.35%102K--56K---161K
-Change in payables and accrued expense --311K209.48%359K44.40%335K--116K--232K
-Change in other current liabilities --0--0-81.33%14K--2K--75K
Cash from discontinued investing activities
Operating cash flow ---3.45M-38.57%-3.18M-43.72%-10.95M---2.29M---7.62M
Investing cash flow
Cash flow from continuing investing activities -86K76.92%-30K-281.33%-572K-130K-150K
Net PPE purchase and sale ---86K76.92%-30K-281.33%-572K---130K---150K
Cash from discontinued investing activities
Investing cash flow ---86K76.92%-30K-281.33%-572K---130K---150K
Financing cash flow
Cash flow from continuing financing activities 12K265.34%8M26.48%11.62M2.19M9.19M
Net issuance payments of debt ----------0------637K
Net common stock issuance --12K-99.95%1K35.91%11.62M--2.19M--8.55M
Net other financing activities --0--8M------------
Cash from discontinued financing activities
Financing cash flow --12K265.34%8M26.48%11.62M--2.19M--9.19M
Net cash flow
Beginning cash position --6.97M4.66%2.18M213.88%2.08M--2.08M--663K
Current changes in cash ---3.52M2,166.81%4.8M-93.09%98K---232K--1.42M
End cash Position --3.45M277.12%6.97M4.71%2.18M--1.85M--2.08M
Free cash flow ---3.54M-32.37%-3.21M-48.31%-11.52M---2.42M---7.77M
Currency Unit USDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data